Valente W A, Vitti P, Rotella C M, Vaughan M M, Aloj S M, Grollman E F, Ambesi-Impiombato F S, Kohn L D
N Engl J Med. 1983 Oct 27;309(17):1028-34. doi: 10.1056/NEJM198310273091705.
We used a strain of differentiated rat-thyroid cells in continuous culture (the FRTL-5 strain) to detect the presence of growth-promoting antibodies in serum samples from patients with autoimmune thyroid disease. We found that IgG preparations from 17 of 20 patients (85 per cent) with active Graves' disease and two of five patients (40 per cent) with Hashimoto's thyroiditis could augment thyroid-cell growth. In parallel with IgG-induced elevations in intracellular cyclic AMP levels in the same cell line, all 20 of the patients with active Graves' disease had thyroid-stimulatory antibodies. Patients' IgG preparations fell into three subclasses: those with both potent cyclic AMP stimulation and potent growth-promoting activity; those with potent cyclic AMP stimulation but low-level growth promotion; and those with potent growth promotion and low-level cyclic AMP action. Growth-promoting antibodies were not detected in patients with Graves' disease in remission (seven patients), nodular goiter (seven), subacute thyroiditis (five), or atrophic thyroiditis (one). Simultaneous assays of growth promotion and cyclic AMP stimulation may be useful in the care of patients with autoimmune thyroid disease.
我们使用连续培养的分化型大鼠甲状腺细胞系(FRTL - 5细胞系)来检测自身免疫性甲状腺疾病患者血清样本中促生长抗体的存在情况。我们发现,20例活动性格雷夫斯病患者中的17例(85%)以及5例桥本甲状腺炎患者中的2例(40%)的IgG制剂能够促进甲状腺细胞生长。与同一细胞系中IgG诱导的细胞内环磷酸腺苷(cAMP)水平升高同时出现的是,所有20例活动性格雷夫斯病患者均有甲状腺刺激抗体。患者的IgG制剂分为三个亚类:具有强效cAMP刺激和强效促生长活性的;具有强效cAMP刺激但促生长作用较弱的;以及具有强效促生长作用但cAMP作用较弱的。在格雷夫斯病缓解期患者(7例)、结节性甲状腺肿患者(7例)、亚急性甲状腺炎患者(5例)或萎缩性甲状腺炎患者(1例)中未检测到促生长抗体。同时进行促生长和cAMP刺激检测可能有助于自身免疫性甲状腺疾病患者的治疗。